BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 1 June 2021
Name of applicant:
ASTRAZENECA PLC
Name of scheme:
ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS-RELATED SHARE OPTION PLAN; ASTRAZENECA ALL-EMPLOYEE SHARE PLAN; ASTRAZENECA PLC 2012 SAVINGS-RELATED SHARE OPTION SCHEME
Period of return:
From:
1 DECEMBER 2020
To:
31 MAY 2021
Balance of unallotted securities under scheme(s) from previous return:
709,452
Plus:The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
5,000,000
Less:Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
456,674
Equals:Balance under scheme(s) not yet issued/allotted at end of period:
5,252,778
Name of contact:
HANNAH TATTERSALL
Telephone number of contact:
+44 (0)746 498 2582
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Adrian Kemp
Company Secretary
AstraZeneca PLC

Attachments

  • Original document
  • Permalink

Disclaimer

AstraZeneca plc published this content on 01 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 June 2021 16:30:03 UTC.